We studied 76 patients with endocrinological features of prolactin-sec
reting microadenoma by MRI, using three dimensional (3D) gradient echo
acquisition (FLASH) sequences. MRI revealed a focal signal abnormalit
y in the pituitary in all 37 patients who had not previously taken bro
mocriptine. However, focal abnormality was shown in only half the pati
ents had been on dopamine agonist therapy; the MRI findings in these 3
9 patients were not affected by the duration and dosage bromocriptine,
nor by the time elapsed since its discontinuation. The microadenoma g
ave spontaneous high signal on the unenhanced T1-weighted images in 8
cases; it was not seen on unenhanced images in 25 cases. It appeared a
s low signal within the enhancing gland in 51 cases but enhanced in 7
cases. The 3D technique gives thin (1 mm) slices and therefore facilit
ates detection of small focal abnormalities in the pituitary gland (2x
2 mm). In the 19 previously treated patients in whom MRI did not demon
strate a focal abnormality, it showed localised atrophy of the gland i
n 3, a large, round gland with homogeneous signal in 1, and a heteroge
neous appearance in 11; it was normal in 4 cases.